FDA Regulatory Uncertainty Calls for Strategic Decision-Making by Drug Developers
By EsqSocial Corporation 07/04/25
The recent reductions in the US Food and Drug Administration’s workforce are poised to have a substantial impact on drug and biologic development programs. This LawFlash discusses strategies to optimize interactions with the Agency and keep development programs on track....
By: Morgan Lewis